cbdMD Inc (YCBD)
0.90
0.00 (0.00%)
USD |
NYAM |
Apr 26, 16:00
0.90
0.00 (0.00%)
After-Hours: 20:00
cbdMD Gross Profit Margin (Quarterly): 66.18% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 66.18% |
September 30, 2023 | 62.14% |
June 30, 2023 | 62.84% |
March 31, 2023 | 64.35% |
December 31, 2022 | 58.63% |
September 30, 2022 | 63.22% |
June 30, 2022 | 69.04% |
March 31, 2022 | 66.91% |
December 31, 2021 | 53.57% |
September 30, 2021 | 58.64% |
June 30, 2021 | 68.08% |
March 31, 2021 | 69.12% |
December 31, 2020 | 72.18% |
September 30, 2020 | 54.41% |
June 30, 2020 | 64.76% |
March 31, 2020 | 70.93% |
Date | Value |
---|---|
December 31, 2019 | 63.54% |
September 30, 2019 | 56.75% |
June 30, 2019 | 63.41% |
March 31, 2019 | 66.03% |
December 31, 2018 | 64.46% |
September 30, 2018 | 73.04% |
June 30, 2018 | 65.40% |
March 31, 2018 | 83.00% |
December 31, 2017 | 66.83% |
September 30, 2017 | 50.64% |
June 30, 2017 | 85.37% |
March 31, 2017 | 71.72% |
December 31, 2016 | 18.56% |
September 30, 2016 | -60.48% |
June 30, 2016 | 16.64% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
53.57%
Minimum
Dec 2021
72.18%
Maximum
Dec 2020
63.62%
Average
63.54%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 48.70% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -106.1% |
Return on Assets | -74.73% |
Return on Invested Capital | -106.0% |
Profit Margin (Quarterly) | -18.54% |
Operating Margin (Quarterly) | -19.83% |
Return on Net Operating Assets | -92.21% |